.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Covington
Teva
AstraZeneca
Express Scripts
Chubb
Baxter
Fish and Richardson
Julphar
Daiichi Sankyo

Generated: November 19, 2017

DrugPatentWatch Database Preview

Navinta Llc Company Profile

« Back to Dashboard

What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?

NAVINTA LLC has nine approved drugs.



Summary for Navinta Llc

US Patents:0
Tradenames:9
Ingredients:9
NDAs:9
Drug Master File Entries: 20
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Navinta Llc
BENZTROPINE MESYLATE
benztropine mesylate
INJECTABLE;INJECTION091525-001Feb 5, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
ROPIVACAINE HYDROCHLORIDE
ropivacaine hydrochloride
SOLUTION;INJECTION078601-003Jul 17, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
FOMEPIZOLE
fomepizole
INJECTABLE;INJECTION078537-001Mar 6, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)205880-001Aug 4, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
RIBAVIRIN
ribavirin
FOR SOLUTION;INHALATION207366-001Oct 6, 2016ANRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
INJECTABLE;INJECTION202938-001Mar 28, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
INDOMETHACIN SODIUM
indomethacin sodium
INJECTABLE;INJECTION206561-001Jul 19, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
FAMOTIDINE
famotidine
FOR SUSPENSION;ORAL091020-001May 27, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
ROPIVACAINE HYDROCHLORIDE
ropivacaine hydrochloride
SOLUTION;INJECTION078601-002Jul 17, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
NICARDIPINE HYDROCHLORIDE
nicardipine hydrochloride
INJECTABLE;INJECTION090125-001Nov 17, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Chinese Patent Office
UBS
Novartis
Colorcon
McKesson
Cerilliant
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot